PMC:7252011 / 8725-8868
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
266 | 97-105 | Species | denotes | patients | Tax:9606 |
268 | 54-82 | Chemical | denotes | low molecular weight heparin | MESH:D006495 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T65 | 75-82 | Body_part | denotes | heparin | http://purl.org/sig/ont/fma/fma82839 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T57 | 10-23 | Chemical | denotes | anticoagulant | http://purl.obolibrary.org/obo/CHEBI_50249 |
T58 | 75-82 | Chemical | denotes | heparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T61 | 0-143 | Sentence | denotes | Use of an anticoagulant therapy, as, for example with low molecular weight heparin, improves the patients’ outcome and reduces lethality [3,4]. |